护士驱动糖尿病酮症酸中毒静脉胰岛素方案调整后的临床结局
该研究为单中心回顾性前后对照队列,纳入250例成人DKA患者(前组125例、后组125例),比较2022年更新护士驱动静脉胰岛素方案(增加实验室评估间的固定速率计算)前后的结局。主要终点DKA缓解时间无显著差异(前组15小时[IQR 10.5-21.5] vs 后组16.5小时[IQR 11-21],p=0.92)。后组至少一次低血糖事件比例较低(8.0% vs 15.2%),但差异无统计学意义(p=0.076)。后组胰岛素输注时长和住院时间显著延长。结论认为现行护士驱动方案安全且与旧方案同样有效。
要点
- 在成人DKA护士驱动方案中,更新后DKA缓解时间与旧方案无差异(16.5小时 vs 15小时,p=0.92)。
- 更新方案后至少一次低血糖事件比例从15.2%降至8.0%,但未达统计学显著(p=0.076)。
- 更新方案后胰岛素输注时长和住院时间显著延长。
- 该研究为单中心回顾性前后对照,样本量250例,结论需前瞻性验证。
适用人群与场景
- 成人糖尿病酮症酸中毒(DKA)患者,接受护士驱动静脉胰岛素方案治疗。
- 单中心学术医疗中心,急诊/住院场景。
诊断标准与关键阈值
- 原文未提及DKA诊断标准的具体条件或界值。
- 原文未提及方案启动、停止或调整的阈值。
处置流程与药物剂量
- 护士驱动静脉胰岛素方案:2022年更新版在实验室评估之间增加固定速率计算(standing rate calculations),具体剂量、单位、途径、频次原文未提及。
- 原文未提及补液、电解质管理等其他处置细节。
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的红旗征。
研究设计与关键结果
- 研究类型:单中心回顾性前后对照队列研究,样本量250例(前组125例,后组125例)。
- 主要终点:DKA缓解时间无显著差异(前组15小时[IQR 10.5-21.5] vs 后组16.5小时[IQR 11-21],p=0.92)。
- 次要终点:至少一次低血糖事件比例后组8.0% vs 前组15.2%,差异无统计学意义(p=0.076)。
- 次要终点:后组胰岛素输注时长和住院时间显著延长。
- 其他次要终点(患者去向)原文未报告具体数值。
证据类型、等级与局限
- 证据类型:单中心回顾性前后对照队列研究。
- 局限:回顾性设计、单中心、样本量有限、前后对照非随机化。
对床旁实践的改变
- 更新护士驱动DKA方案(增加实验室评估间固定速率计算)未缩短DKA缓解时间,但可能降低低血糖事件比例(未达统计学显著)。
- 需注意更新方案后胰岛素输注时长和住院时间延长,临床使用中应关注此趋势。
- 该研究为单中心回顾性,结论不能外推为所有DKA患者的通用推荐。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Limited literature exists to support the safety and efficacy of a nurse-driven protocol for the management of diabetic ketoacidosis (DKA). Our institution's nurse-driven protocol was updated in 2022 to improve outcomes and safety by adding standing rate calculations between lab assessments.
OBJECTIVE: To compare patient outcomes following changes made to a nurse-driven DKA protocol at an academic medical center.
METHODS: This was a retrospective, single-center, pre-post cohort study that included adult DKA patients receiving the nurse-driven protocol. The primary outcome was time from DKA diagnosis to resolution. Secondary outcomes included frequency of hypoglycemic events, insulin infusion duration, patient disposition, and hospital length of stay. Comparisons between protocols were made using the Wilcoxon rank-sum test for continuous variables and the chi-square test for categorical variables.
RESULTS: 250 patients were included, with 125 patients in the pre- and 125 patients in the post-implementation group. There was no statistically significant difference in the time to DKA resolution between groups (pre- 15 h [IQR 10.5-21.5] versus post- 16.5 h [IQR 11-21], p = 0.92). The proportion of patients experiencing at least one hypoglycemic event was lower in the post-implementation group (8.0% vs 15.2%), although this difference was not significant (p = 0.076). Insulin infusion duration and hospital length of stay were significantly longer in the post-implementation group.
CONCLUSION: Our current nurse-driven protocol is both safe and as equally effective as our previous institutional protocol.
参考来源
- Savidge M, Martinelli A, Chea T, et al. Clinical outcomes following changes to a nurse-driven diabetic ketoacidosis intravenous insulin protocol. Am J Emerg Med. 2026. PMID: 42628315. doi:10.1016/j.ajem.2026.08.020
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。